371 related articles for article (PubMed ID: 33227992)
21. Mechanisms of tumor necrosis factor-alpha-induced interleukin-6 synthesis in glioma cells.
Tanabe K; Matsushima-Nishiwaki R; Yamaguchi S; Iida H; Dohi S; Kozawa O
J Neuroinflammation; 2010 Mar; 7():16. PubMed ID: 20205746
[TBL] [Abstract][Full Text] [Related]
22. Dibutyryl cAMP- or Interleukin-6-induced astrocytic differentiation enhances mannose binding lectin (MBL)-associated serine protease (MASP)-1/3 expression in C6 glioma cells.
Pagliara V; Parafati M; Adornetto A; White MC; Masullo M; Grimaldi M; Arcone R
Arch Biochem Biophys; 2018 Sep; 653():39-49. PubMed ID: 29963999
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-6 and the soluble interleukin-6 receptor induce stem cell factor and Flt-3L expression in vivo and in vitro.
Peters M; Solem F; Goldschmidt J; Schirmacher P; Rose-John S
Exp Hematol; 2001 Feb; 29(2):146-55. PubMed ID: 11166453
[TBL] [Abstract][Full Text] [Related]
24. Synergy between IL-6 and soluble IL-6 receptor enhances bone morphogenetic protein-2/absorbable collagen sponge-induced bone regeneration via regulation of BMPRIA distribution and degradation.
Huang RL; Chen G; Wang W; Herller T; Xie Y; Gu B; Li Q
Biomaterials; 2015 Oct; 67():308-22. PubMed ID: 26232880
[TBL] [Abstract][Full Text] [Related]
25. Antitumor progression potential of caffeic acid phenethyl ester involving p75(NTR) in C6 glioma cells.
Lin WL; Liang WH; Lee YJ; Chuang SK; Tseng TH
Chem Biol Interact; 2010 Dec; 188(3):607-15. PubMed ID: 20836997
[TBL] [Abstract][Full Text] [Related]
26. The balance of interleukin (IL)-6, IL-6·soluble IL-6 receptor (sIL-6R), and IL-6·sIL-6R·sgp130 complexes allows simultaneous classic and trans-signaling.
Baran P; Hansen S; Waetzig GH; Akbarzadeh M; Lamertz L; Huber HJ; Ahmadian MR; Moll JM; Scheller J
J Biol Chem; 2018 May; 293(18):6762-6775. PubMed ID: 29559558
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-6 and soluble interleukin-6 receptor suppress osteoclastic differentiation by inducing PGE(2) production in chondrocytes.
Honda K
J Oral Sci; 2011 Mar; 53(1):87-96. PubMed ID: 21467819
[TBL] [Abstract][Full Text] [Related]
28. Effect of soluble interleukin-6 receptor alpha and interleukin-6 secreted by polymorphonuclear leukocytes on tumor necrosis factor-alpha expression and its production by peripheral blood mononuclear cells.
Jablonska E
Mediators Inflamm; 2002 Oct; 11(5):325-8. PubMed ID: 12467526
[TBL] [Abstract][Full Text] [Related]
29. IL-6 inhibits the proliferation of fibroblastic synovial cells from rheumatoid arthritis patients in the presence of soluble IL-6 receptor.
Nishimoto N; Ito A; Ono M; Tagoh H; Matsumoto T; Tomita T; Ochi T; Yoshizaki K
Int Immunol; 2000 Feb; 12(2):187-93. PubMed ID: 10653854
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of gingival inflammation induced by synergism of IL-1β and IL-6.
Sawada S; Chosa N; Ishisaki A; Naruishi K
Biomed Res; 2013 Feb; 34(1):31-40. PubMed ID: 23428978
[TBL] [Abstract][Full Text] [Related]
31. Essential roles of IL-6 trans-signaling in colonic epithelial cells, induced by the IL-6/soluble-IL-6 receptor derived from lamina propria macrophages, on the development of colitis-associated premalignant cancer in a murine model.
Matsumoto S; Hara T; Mitsuyama K; Yamamoto M; Tsuruta O; Sata M; Scheller J; Rose-John S; Kado S; Takada T
J Immunol; 2010 Feb; 184(3):1543-51. PubMed ID: 20042582
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous activation of signals through gp130, c-kit, and interleukin-3 receptor promotes a trilineage blood cell production in the absence of terminally acting lineage-specific factors.
Kimura T; Sakabe H; Tanimukai S; Abe T; Urata Y; Yasukawa K; Okano A; Taga T; Sugiyama H; Kishimoto T; Sonoda Y
Blood; 1997 Dec; 90(12):4767-78. PubMed ID: 9389693
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-6-type cytokines and their receptors for gene therapy of melanoma.
Mackiewicz A; Wiznerowicz M; Roeb E; Nowak J; Pawlowski T; Baumann H; Heinrich PC; Rose-John S
Ann N Y Acad Sci; 1995 Jul; 762():361-73; discussion 373-4. PubMed ID: 7668537
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-6-mediated trans-signaling inhibits transforming growth factor-β signaling in trabecular meshwork cells.
Inoue-Mochita M; Inoue T; Kojima S; Futakuchi A; Fujimoto T; Sato-Ohira S; Tsutsumi U; Tanihara H
J Biol Chem; 2018 Jul; 293(28):10975-10984. PubMed ID: 29752408
[TBL] [Abstract][Full Text] [Related]
35. Thrombin and PAR-1-AP increase proinflammatory cytokine expression in C6 cells.
Fan Y; Zhang W; Mulholland M
J Surg Res; 2005 Dec; 129(2):196-201. PubMed ID: 16143343
[TBL] [Abstract][Full Text] [Related]
36. The soluble form of interleukin-6 receptor modulates cell proliferation by acute myeloblastic leukemia blast cells.
Säily M; Koistinen P; Savolainen ER
Ann Hematol; 1999 Apr; 78(4):173-9. PubMed ID: 10348148
[TBL] [Abstract][Full Text] [Related]
37. Role of interleukin-6 and soluble IL-6 receptor in region-specific induction of astrocytic differentiation and neurotrophin expression.
März P; Heese K; Dimitriades-Schmutz B; Rose-John S; Otten U
Glia; 1999 May; 26(3):191-200. PubMed ID: 10340760
[TBL] [Abstract][Full Text] [Related]
38. The activation of Toll-like receptor 4 reverses tumor differentiation in human glioma U251 cells via Notch pathway.
Hu J; Shi B; Liu X; Jiang M; Yuan C; Jiang B; Song Y; Zeng Y; Wang G
Int Immunopharmacol; 2018 Nov; 64():33-41. PubMed ID: 30145468
[TBL] [Abstract][Full Text] [Related]
39. Directly linked soluble IL-6 receptor-IL-6 fusion protein induces astrocyte differentiation from neuroepithelial cells via activation of STAT3.
Takizawa T; Yanagisawa M; Ochiai W; Yasukawa K; Ishiguro T; Nakashima K; Taga T
Cytokine; 2001 Mar; 13(5):272-9. PubMed ID: 11243705
[TBL] [Abstract][Full Text] [Related]
40. Optimized mixture of As, Cd and Pb induce mitochondria-mediated apoptosis in C6-glioma via astroglial activation, inflammation and P38-MAPK.
He W; Li Y; Tian J; Jiang N; Du B; Peng Y
Am J Cancer Res; 2015; 5(8):2396-408. PubMed ID: 26396915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
